RELATIONSHIP OF METABOLIC SYNDROME COMPONENTS WITH ELECTROCARDIOGRAPHIC BIOMARKERS OF METABOLIC CARDIOMYOPATHY IN MEN WITH CORONARY ATHEROSCLEROSIS

Aim. To study electrocardiographic (ECG) markers of metabolic cardiomyopathy (MC) and their association with the components and markers of metabolic syndrome (MS) in men with coronary atherosclerosis (CA). Material and methods. Totally 77 men included at the age 42-77 with stenotic CA verified by coronary angiography (CAG), without acute coronary syndrome (ACS) with stable angina (II-IV FC) — inhabitants of the Western Siberia. All patients underwent the recording of resting ECG in 12 standard leads with following coding by Minnesota code. The ECG markers of MC were studied as the QT duration, corrected QX ST segment shift above isoline for more than 0,5 mm, ST depression below isoline >0,5 mm of nonischemic type, T wave changes (platening and amplitude decrease), inversion, TV1>TV6 syndrome (amplitude of T in V1 is higher than T in V6), signs of left ventricle hypertrophy (LVH), rhythm and conduction disorders. In all patients we also assessed the components of MS as waist circumference, body mass index, systolic and diastolic arterial pressure (SBP, DBP),
levels of total cholesterol (TC), low and high density lipoprotein cholesterol (LDL, HDL), C-peptide, glucose.
Results. In men with CA there were following ECG markers of MC found: arrhythmias in 38 patients, LVH in 55, TV1>TV6 in 24, Twave changes in 58, ST elevation in 44, ST depression in 23, prolonged QT in 5. MS in general in the group studied was found in 80,5% of men. The positive correlation was found for the length of QT and SBP values, for ECG signs of LVH with increased levels of TC, for increased C-peptide and ST depression. In the group of the patients with CA and increased C-peptide level relative risk of ST depression was 3,3 times more than in patients with normal C-peptide. In the group of CAand increased LDL relative riskof ECG signs of LVH was 3,8 times more than in CAand normal LDL.
Conclusion. Therefore the presence in coronary atherosclerosis of MS and its constituents is associated with the presence of some ECG biomarkers of MC that shows the partial similarity of the influences of metabolic disorders on development of the diseases.

1. ShostakNA,YakushinSS, FilippovEV. Cardiomyopathy. Cardiology. National guidelines. Ed. BelenkovYuN, Oganov RG. M.: GEOTAR-Media, 2007; 887-900. Russian (ШостакН.А., Якушине.С, ФилипповЕ.В. Кардиомиопатии. Кардиология. Национальное руководство. Под ред. Ю.Н. Беленкова, Р. Г. Оганова. М: ГЭОТАР-Медиа, 2007; 887-900).

2. Timoshenko NA, Ragino Yul, Voevoda Ml. Metabolic cardiomyopathy: state of the problem. Atherosclerosis, 2013; 9 (1): 65-77. Russian (Тимошенко Н.А., РагиноЮ.И., ВоеводаМ.И. Метаболическая кардиомиопатия. Современное состояние проблемы. Атеросклероз, 2013; 9 (1): 65-77).

3. Semernin EN, Gudkova AYa. Metabolic cardiomyopathies: system and cardiomyopathy karnitin deficiency, lipotoxic cardiomyopathy. Bulletin of the federal center of heart, blood and endocrinology of V.A. Almazov. 2010; 5: 24-38. Russian (Семернин Е.Н., Гудкова А.Я. Метаболические кардиомиопатии: системный и кардиомиопатический карнитиновый дефицит, липотоксическая кардиомиопатия. Бюллетень федерального центра сердца, крови и эндокринологии им. В. А. Алмазова, 2010; 5: 24-38).

4. Chumakova GA, Veselovsky NG, Kozarenko AA, et al. Features of morphology, structure and function of heart in obesity. Russ J Cardiol, 2012; 4 (96): 93-9. Russian (Чумакова Г. А., Веселовская Н.Г., Козаренко А. А. и др. Особенности морфологии, структуры и функции сердца при ожирении. Российский кардиологический журнал, 2012; 4 (96): 93-9).

5. SemenovaLV, Gagarin VI, ProkopyevES. Electrocardiography in diagnostics of diseases of cardiovascular system (the methodical management). International journal of applied and basic researches, 2013; 2:24-5. Russian (Семенова Л. В., Гагарин В. И., Прокопьев Е.С. Электрокардиография в диагностике заболеваний сердечно-сосудистой системы (методическое руководство). Международный журнал прикладных и фундаментальных исследований, 2013; 2: 24-5).

6. Shurygina VD, Shubik YV. Cardiac rhythm disorders and metabolic syndrome. Bulletin arrhythmology. 2008, 53: 56-63. Russian (Шурыгина В.Д., ШубикЮ.В. Нарушения ритма сердца при метаболическом синдроме. Вестникаритмологии. 2008; 53:56-63).

7. Paksoy F, Ulas T, Bes С, et al. Corrected Qt interval in patients with metabolic syndrome. DicleMedJ.2011;38: 274-7.

8. Goldberger JJ, Cain ME, Hohnloser SH, et al. American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death. A Scientific Statement From the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention. JACC. 2008; 52; 1179-99.

9. Soydinc S, Davutoglu V, AkcayM. Uncomplicated metabolic syndrome is associated with prolonged electrocardiographic QTc interval and QTc dispersion. Ann Noninvasive Electrocardiol.2006; 11:313-7.

10. Ferrara LA, Cardoni 0, Mancini M, et al. Metabolic syndrome and left ventricular hypertrophy in a general population. Results from the Gubbio Study. J Hum Hypertens. 2007; 21:795-801.

11. Guerra F, Mancinelli L, Angelini L, et al. The Association of Left Ventricular Hypertrophy with Metabolic Syndrome is Dependent on Body Mass Index in Hypertensive Overweight or Obese Patients. PLoS One. 2011; 6 (1): e16630.

12. Diagnosis and treatment of metabolic syndrome. Russian recommendations. Russian Scientific Society of Cardiology. Cardiovascular Therapy and Prevention 2009; 8(6): 36 p, Suppl. 2. Russian (Диагностика и лечение метаболического синдрома. Российские рекомендации. Всероссийское научное общество кардиологов. Кардиоваскулярная терапия и профилактика 2009; 8(6): 36 с, приложение 2).

13. Voevoda Ml, Ragino Yul, Chernjavski AM, et al. High prevalence of metabolic syndrome in men with coronary atherosclerosis in Siberia. Russian Journal of Cardiology, 2010; 1: 65-70. Russian (Воевода М. И., Рагино Ю. И., Чернявский А. М. и др. Высокая распространенность метаболического синдрома у мужчин с коронарным атеросклерозом в Сибири. Российский кардиологический журнал, 2010; 1:65-70).

14. Wong С, Marwick TH. Obesity cardiomyopathy: pathogenesis and pathophysiology. Nat Clin Pract Cardiovasc Med., 2007; 4:436-43.

15. Timoshenko NA, Ragino Yul, Chernjavski AM, et al. Association of electrocardiographic markers of metabolic card iomyopathywith long-term results of myoca rdial revascularization in men with coronary atherosclerosis. Russian Journal of Cardiology, 2014, 6(110): 57-61. Russian (Тимошенко Н.А., РагиноЮ.И., Чернявский A.M. и др. Связь электрокардиографических маркеров метаболической кардиомиопатии с отдаленными результатами реваскуляризации миокарда у мужчин с коронарным атеросклерозом. Российский кардиологический журнал, 2014, 6(110): 57-61).